Recruiting NCT07681999

Detection of Early Scapular Dyskinesis

— Observational Scapular Dyskinesis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to: Registry conditions: Scapular Dyskinesis. Basic parameters: from 18 years · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: Egypt
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Detection of Early Inflammatory Versus Early Mechanical Scapular Dyskinesis

Overview

This study is a prospective blind contrast between periscapular muscle thickness measured with MSUS in patients with early AS in comparison to patients with mechanical dyskinesis and to correlate it with EMG findings.

Primary outcome measures

periscapular muscle thickness measured with MSUS in patients with early ASversus patients with mechanical dyskinesis [Time frame: day 1 (At the same time of initial examination)]

Eligibility criteria

Inclusion criteria

treatment-naïve patients with ankylosing spondylitis (AS), who fulfilled the Assessment of Spondylarthritis Society (ASAS) criteria for axial spondyloarthritis (ax-SpA)
Inclusion criterion for the second group (non-AS individuals) was patients complaining of discomfort upon activity.

Exclusion criteria

The exclusion criteria of the first group included:

patients with a history of local trauma
and/or surgical intervention,
neuromascular deﬁcits,
chronic chest disease and
other inﬂammatory autoimmune/rheumatologic conditions.
Exclusion criteria for the second group were:

a history of AS or
other systemic autoimmune/ rheumatologic disease.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model: Other

Study locations

Egypt · 1 center

Faculty of medicine, Tanta University — Tanta

Identifiers

NCT: NCT07681999 · 36264PR770/7/24

Primary sources (government registries)

ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗